Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Current Assets (2020 - 2023)

Historic Current Assets for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $45.1 million.

  • Candel Therapeutics' Current Assets fell 4296.07% to $45.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $45.1 million, marking a year-over-year decrease of 4296.07%. This contributed to the annual value of $71.9 million for FY2022, which is 1530.4% down from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Current Assets is $45.1 million, which was down 4296.07% from $53.4 million recorded in Q2 2023.
  • Candel Therapeutics' 5-year Current Assets high stood at $95.6 million for Q1 2022, and its period low was $24.4 million during Q2 2021.
  • In the last 4 years, Candel Therapeutics' Current Assets had a median value of $71.9 million in 2022 and averaged $66.3 million.
  • As far as peak fluctuations go, Candel Therapeutics' Current Assets skyrocketed by 25751.25% in 2022, and later tumbled by 4296.07% in 2023.
  • Candel Therapeutics' Current Assets (Quarter) stood at $35.1 million in 2020, then soared by 141.69% to $84.9 million in 2021, then fell by 15.3% to $71.9 million in 2022, then crashed by 37.31% to $45.1 million in 2023.
  • Its Current Assets was $45.1 million in Q3 2023, compared to $53.4 million in Q2 2023 and $61.9 million in Q1 2023.